Morning Briefing
Summaries of health policy coverage from major news organizations
In Face Of Intense Government Scrutiny, Juul To Retool Product To Lower Nicotine Levels
The New York Times: Juul’s New Product: Less Nicotine, More Intense Vapor
Juul Labs has soared to the top of the United States e-cigarette market in just three years with its high-nicotine products that give off just a wisp of vapor. Now, facing public backlash and overseas restrictions, the company is working on a way to lower the nicotine in its pods — but still maintain a potent punch from the addictive chemical. Juul is developing a pod that is higher in vapor, which, experts say, can enhance the rate at which nicotine is absorbed in the body. (Kaplan, 11/27)
In other health industry news —
The Wall Street Journal: Unilever Looks To Acquire GlaxoSmithKline’s Nutrition Business
Unilever PLC is in talks to acquire GlaxoSmithKline PLC’s nutrition business, people familiar with the matter said, a deal that would hand the consumer-goods giant one of India’s best-known brands. If finalized, a deal would end a monthslong auction process that also drew interest from Nestle SA and Coca-Cola Co. , who were all eager to bolster their presence in one of the world’s most promising consumer markets. (Dummett, Chaudhuri and Roland, 11/27)
